Rheinmetall's Cash-Flow Conundrum Takes Centre Stage Ahead of Thursday's Full-Year Interim Report
Published on 08/05/2026 at 16:02 | Redaktion boerse-global.de
The defence contractor's shares have been climbing steadily in the run-up to tomorrow's full half-year results, but the real test lies not in the headline growth figures — already flagged three weeks ago — but in whether management can convince the market that a deeply negative operating cash flow is a temporary blip rather than a structural drag.
The stock added 2.01 percent on Wednesday to trade at 1,226.40 euros, extending a 30-day advance of 7.96 percent. That recovery has lifted the shares well clear of their 52-week low of 902.50 euros, though the equity still sits roughly 40 percent below the record high of just over 2,007 euros touched in early October. The market capitalisation currently stands at around 55 billion euros.
A Blowout Quarter With a Catch
The optimism traces back to 29 July, when Rheinmetall released preliminary second-quarter figures that blew past consensus. Revenue surged 69 percent to 3.289 billion euros — a figure that comfortably exceeded the roughly 1.9 billion euros analysts had pencilled in, and also came in ahead of the 3.25 billion euros some forecasts had suggested. Operating profit climbed to 562 million euros against expectations of 469.9 million, delivering a margin of 17.1 percent.
The catch: operating free cash flow swung sharply negative, which the DĂĽsseldorf-based group attributed to delayed customer prepayments and heavy inventory build-up ahead of scheduled deliveries. That explanation will face close scrutiny during Thursday's analyst webcast, as investors weigh whether the cash outflow is genuinely one-off or signals a recurring pattern that could cap the valuation. Consensus points to earnings per share of 6.06 euros for the quarter, up from 2.90 euros a year earlier.
Should investors sell immediately? Or is it worth buying Rheinmetall?
For the full year 2026, analysts expect EPS of 37.84 euros versus 15.38 euros in 2025, on revenue of 14.03 billion euros compared with 9.94 billion euros previously.
Naval Ambitions and a Steady Stream of Orders
Alongside the numbers, Rheinmetall has been busy padding its order book. On Monday, the group unveiled the GMF 140, a guided-missile frigate developed jointly with NVL. The 140-metre vessel displaces more than 6,000 tonnes, carries 64 vertical launch system cells for air defence and long-range strikes, and is fitted with Lockheed Martin's AEGIS combat system and US radar technology. Capable of around 30 knots and housing a crew of over 90 plus 35 additional personnel, the ship is aimed squarely at North American buyers — Canada and the US first, then other NATO partners. Pricing and delivery timelines have yet to be disclosed.
The naval push extends to modernisation work closer to home. The German Navy has commissioned Rheinmetall to upgrade the F123-class frigate "Bayern," a contract in the mid-hundreds of millions of euros covering the enhancement of command and weapons systems through 2029.
On the land-systems front, the group's US subsidiary American Rheinmetall received an army development contract in late July for autonomous unmanned ground vehicles under "Project Sustainment." The company is also pitching its Lynx XM30 — a vehicle with a two-person crew, six infantry seats and a 50-millimetre turret with modular armour — as a replacement for the US Army's Bradley, putting it in direct competition with General Dynamics.
Medical Orders and the Ukraine Connection
The order flow extends into battlefield medical support. Under a framework agreement signed in December 2024, the German government has called off 149 mobile rescue stations from Rheinmetall Project Solutions — 112 of them ballistically protected and 37 unprotected. The order forms part of a NATO initiative for modular medical facilities; comparable systems have been in Ukrainian service since September 2023, and Rheinmetall delivered five armoured MEDIGUARD vehicles to Ukraine's National Guard on 10 April.
Rheinmetall at a turning point? This analysis reveals what investors need to know now.
Analyst Endorsements and the Road Ahead
The preliminary results have prompted at least one notable upgrade. Bernstein Research raised its price target on 29 July from 1,700 to 1,900 euros, reaffirming an "Outperform" rating, while Jefferies reiterated its buy recommendation with a 1,300-euro target the same day.
Whether the shares can sustain their recent momentum after Thursday's full report will hinge on two things: how convincingly management explains the cash-flow dynamics, and whether the group raises its full-year guidance. With the order book expanding across naval, land and medical segments, the underlying demand story remains intact — but the market wants proof that growth is translating into cash, not just contracts.
Ad
Rheinmetall Stock: New Analysis - 5 August
Fresh Rheinmetall information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
